Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response

• Marc Radtke,
• Curdin Conrad,
• Christopher Schuster,
• Daniel Saure,
• Can Mert,
• Elisabeth Riedl,
• Antonio Costanzo

Affiliations

Marc Radtke

Dermatologikum Hamburg GmbH

Curdin Conrad

Centre Hospital University Vaudois

Christopher Schuster

Eli Lilly and Company, Indianapolis

Daniel Saure

Eli Lilly and Company, Indianapolis

Can Mert

HaaPacs GmbH

Elisabeth Riedl

Eli Lilly and Company, Indianapolis

Antonio Costanzo

Humanitas University and IRCCS Humanitas Research Hospital